PHENYLALKYL N-HYDROXYUREAS FOR TREATING LEUKOTRIENE RELATED PATHOLOGIES
摘要
The method of treating patients by administering N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea for treatment of leukotriene related pathologies, and compositions for this use.
申请公布号
EP2598141(A4)
申请公布日期
2013.12.18
申请号
EP20110813014
申请日期
2011.07.25
申请人
TALLIKUT PHARMACEUTICALS, INC.
发明人
TAUB, REBECCA;BROTZ, TILMANN;FRANC, JOHN;COHEN, LARRY;PATEL, HEMANTKUMAR H.;CHEMBURKAR, SANJAY R.;SAWICK, DAVID P.